Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Abnormal bleeding tendency (abnormal bleeding), Factor XIII subunit B deficiency, and Reduced factor XIII activity; and common findings: Prolonged bleeding after surgery and Abnormal umbilical stump bleeding. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Abnormal bleeding tendency (abnormal bleeding), Prolonged bleeding after surgery, Abnormal umbilical stump bleeding |
F13B encodes coagulation factor XIII B chain (661 aa). The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin
Factor XIII, b subunit, deficiency of is caused by mutations in the F13B gene on chromosome 1.
F13B is classified as a druggable target (Druggable Genome and Enzyme categories) with score 0.0.
Genetic testing for F13B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for factor XIII, b subunit, deficiency of has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 2 common features.
No clinical trials have been registered for factor XIII, b subunit, deficiency of.
14 publications have been identified in PubMed for factor XIII, b subunit, deficiency of. Research spans Review / Meta-Analysis (57%), Basic Science / Preclinical (21%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 57% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 8:12 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Age of onset: newborn period.
Laboratory research
3 |
21% |
Testing and diagnosis research | 2 | 14% |
Patient case studies | 1 | 7% |
Malkhassian D (2026). [PMID: 30855859](https://pubmed.ncbi.nlm.nih.gov/30855859/). *Unknown Journal*. [Review / Meta-Analysis]
Mangla A (2026). [PMID: 32491399](https://pubmed.ncbi.nlm.nih.gov/32491399/). *Unknown Journal*. [Review / Meta-Analysis]
Ichinose A (2026). [PMID: 40506046](https://pubmed.ncbi.nlm.nih.gov/40506046/). *Semin Thromb Hemost*. [Review / Meta-Analysis]
Jacobs JW (2026). [PMID: 41583548](https://pubmed.ncbi.nlm.nih.gov/41583548/). *Clin Hematol Int*. [Review / Meta-Analysis]
Kim J (2026). [PMID: 41176274](https://pubmed.ncbi.nlm.nih.gov/41176274/). *J Mol Diagn*. [Diagnostic / Biomarker]
Pellerito M (2026). [PMID: 41587469](https://pubmed.ncbi.nlm.nih.gov/41587469/). *Blood Adv*. [Basic Science / Preclinical]
Zichao X (2026). [PMID: 41894265](https://pubmed.ncbi.nlm.nih.gov/41894265/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Tourbih H (2025). [PMID: 40747195](https://pubmed.ncbi.nlm.nih.gov/40747195/). *Cureus*. [Review / Meta-Analysis]
Tsunemine H (2025). [PMID: 39589696](https://pubmed.ncbi.nlm.nih.gov/39589696/). *Int J Hematol*. [Case Report / Case Series]
Singh S (2025). [PMID: 39447073](https://pubmed.ncbi.nlm.nih.gov/39447073/). *Blood*. [Basic Science / Preclinical]